Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
88.07
-1.96 (-2.18%)
Official Closing Price
Updated: 7:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Accenture And 3 Other Stocks Insiders Are Selling
↗
July 19, 2022
Johnson & Johnson (NYSE: JNJ) reported upbeat earnings for its second quarter, but lowered its FY22 guidance. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
What 7 Analyst Ratings Have To Say About Boston Scientific
↗
July 15, 2022
Over the past 3 months, 7 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
↗
July 12, 2022
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.8% on an annualized basis producing an average annual return of 20.73%. Currently, Boston Scientific has a market...
Via
Benzinga
How Is The Market Feeling About Boston Scientific?
↗
June 29, 2022
Boston Scientific's (NYSE:BSX) short percent of float has risen 25.0% since its last report. The company recently reported that it has 19.02 million shares sold short, which is 1....
Via
Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
↗
June 27, 2022
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual return of 20.68%. Currently, Boston Scientific has a market...
Via
Benzinga
Boston Scientific Buys Substantial Stake In Korean MedTech Player
↗
June 15, 2022
Via
Benzinga
Where Boston Scientific Stands With Analysts
↗
May 27, 2022
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
5 Analysts Have This to Say About Boston Scientific
↗
April 28, 2022
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
↗
July 06, 2022
Upgrades
Via
Benzinga
5 Analysts Have This to Say About Boston Scientific
↗
June 24, 2022
Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
June 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Boston Scientific Jumps On Upbeat Q2, FY22 Guidance
↗
April 27, 2022
Via
Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
↗
June 10, 2022
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.09% on an annualized basis producing an average annual return of 20.41%. Currently, Boston Scientific has a market...
Via
Benzinga
Peering Into Boston Scientific's Recent Short Interest
↗
June 10, 2022
Boston Scientific's (NYSE:BSX) short percent of float has risen 20.45% since its last report. The company recently reported that it has 15.00 million shares sold short, which...
Via
Benzinga
Boston Scientific Details How It Is Advancing Equity in Workplaces, Health Care Systems and Communities While Taking Action for a Healthier Planet
June 01, 2022
SOURCE: Boston Scientific
Via
3BL Media
If You Invested $1000 In Boston Scientific 10 Years Ago, Here's How Much You Would Have Today
↗
May 27, 2022
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.68% on an annualized basis producing an average annual return of 21.79%. Currently, Boston Scientific has a market...
Via
Benzinga
This Foreboding Sign Looms Over Boston Scientific's Chart
↗
May 16, 2022
If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the...
Via
Benzinga
Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook
↗
April 28, 2022
Via
Benzinga
Boston Scientific Ekes Out A Narrow First-Quarter Beat, Offers So-So Sales Guide
↗
April 27, 2022
Boston Scientific narrowly topped first-quarter expectations and offered sales guidance that just met forecasts. BSX stock popped.
Via
Investor's Business Daily
Recap: Boston Scientific Q1 Earnings
↗
April 27, 2022
Boston Scientific (NYSE:BSX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Boston Scientific reported...
Via
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
↗
April 24, 2022
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...
Via
Benzinga
Goldman Sachs And 3 Other Stocks Insiders Are Selling
↗
April 22, 2022
Although gold futures traded lower this morning on Friday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
April 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
↗
April 04, 2022
Health remains a tricky investment area, but Evercore analysts say there are safe bets.
Via
Investor's Business Daily
CNBC's Final Trades: Amazon, FedEx And These Health Care Picks
↗
March 20, 2022
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said that Amazon.com, Inc.
Via
Benzinga
All The Stocks That Moved Friday From CNBC's 'Fast Money: Halftime Report'
↗
March 18, 2022
CNBC's "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often move the stocks mentioned....
Via
Benzinga
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
↗
March 15, 2022
Elective procedures are recovering slowly as Covid cases decline. Will they ever boom?
Via
Investor's Business Daily
Hopeful Golden Cross Forms On Boston Scientific's Chart
↗
March 01, 2022
If history is any guide, there may be good fortune ahead for shares of Boston Scientific (NYSE:BSX). A so-called "golden cross" has formed on its chart and, not surprisingly,...
Via
Benzinga
Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs
↗
February 28, 2022
Medical imaging Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 96.
Via
Investor's Business Daily
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
↗
February 23, 2022
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance.
Via
Investor's Business Daily
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today